Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.585 USD | -3.71% |
|
-9.37% | -7.00% |
24/06 | Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12 | MT |
21/06 | Top Premarket Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.00% | 223M | |
+16.38% | 122B | |
+21.38% | 116B | |
+22.18% | 27.03B | |
-21.23% | 20.36B | |
-16.89% | 16.43B | |
-18.28% | 15.91B | |
-44.74% | 15.6B | |
+61.54% | 14.94B | |
+3.38% | 13.59B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 07